Cited by 92Dementia and Cognitive Impairment ResearchHistorical and Modern Theater StudiesAlzheimer's disease research and treatments

Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium

Open access
Miyagawa, Toji, Brushaber, Danielle, Syrjanen, Jeremy, Kremers, Walter, Fields, Julie, Forsberg, Leah K., Heuer, Hilary W., Knopman, David +5 more·2020·Alzheimer's & Dementia

Abstract

Introduction: Behavior/Comportment/Personality (BEHAV) and Language (LANG) domains were added to the Clinical Dementia Rating (CDR®) for improving evaluation of patients with frontotemporal lobar degeneration (FTLD) (CDR® plus NACC FTLD). Methods: We analyzed the CDR® plus NACC FTLD among participants from the baseline visit of the Advancing Research and Treatment for Frontotemporal Lobar Degeneration/Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects Consortium. Results: The CDR® plus NACC FTLD was able to detect early symptoms in the mildly impaired participants who were rated as CDR® sum of boxes (CDR®‐SB) = 0. The CDR®‐SB was not sensitive, particularly in participants with mild nonfluent/agrammatic primary progressive aphasia. Participants with familial and sporadic behavioral variant FTD exhibited similar CDR® plus NACC FTLD profiles except that language impairment was more frequent in participants with mild sporadic behavioral variant FTD. Adding the BEHAV and/or LANG domains to the CDR®‐SB significantly enhanced discriminatory power in differentiating among the FTLD spectrum disorders. Discussion: The BEHAV and LANG domains enable the CDR® plus NACC FTLD to capture early symptomatology of FTLD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2019.05.013

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Use of newly developed psychometric measures for characterizing all stages of symptoms in familial FTD research will facilitate the discovery and validation of early FTD biomarkers.

    “Use of newly developed psychometric measures for characterizing all stages of symptoms (e.g., FTLD‐Clinical Dementia Rating, Multidomain Impairment Rating) in familial FTD research will facilitate the discovery and validation of early FTD biomarkers. 51 , 127”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Miyagawa, T., Brushaber, D., Syrjanen, J., Kremers, W., Fields, J., Forsberg, L. K., Heuer, H. W., Knopman, D., Kornak, J., Boxer, A., Rosen, H., Boeve, B., & on Behalf of the ARTFL/LEFFTDS Consortium
Affiliations
  • Mayo Clinic (US)
  • University of California, San Francisco (US)
Corresponding author
Boeve, Bradley
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2020-01
Volume
16
Issue
1
Pages
79-90
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2970934901
Cited by
92
References
34
Citations by year
2026: 12 · 2025: 10 · 2024: 14 · 2023: 13 · 2022: 16 · 2021: 21 · 2020: 4 · 2019: 2
FWCI
8.56
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (U01 AG045390)
  • Centers for Disease Control and Prevention
  • Bristol-Myers Squibb
  • Avid Radiopharmaceuticals
  • Novartis
  • Pfizer
  • Wyeth
  • Huntington's Disease Society of America
  • New York State Department of Health (1510130358)
  • Biogen
  • AbbVie
  • Eli Lilly and Company
  • AstraZeneca
  • Roche
  • Genentech
  • Canadian Institutes of Health Research
  • Alzheimer Society of B.C.
  • BrightFocus Foundation
  • Alzheimer's Drug Discovery Foundation
  • Eisai
  • University of California, San Francisco
  • Parkinson Study Group
  • Parkinsonfonden
  • Michael J. Fox Foundation for Parkinson's Research
  • Janssen Pharmaceuticals
  • Merck
  • Alzheimer's Association
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
frontotemporal lobar degeneration
MeSH terms
Mental Status and Dementia Tests, Adult, Aged, Behavior, Cross-Sectional Studies, Female, Humans, Language, Middle Aged, Personality, Frontotemporal Lobar Degeneration, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review